.png){kind=icon}
.png){kind=icon}
Return
Cleavage-activatable antibody-photosensitizer conjugate enables tumor-selective photodynamic activation and immunogenic cell death
.png){kind=icon}
PRE
AI
Y
S
H
Y
DOI：10.1016/j.jconrel.2026.115212.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• An activatable antibody-photosensitizer conjugate was developed for PDT. • Enzyme-triggered linker cleavage switches photodynamic activity from OFF to ON. • Zwitterionic linker minimizes nonspecific serum protein interactions. • Tumor-selective activation induces spatially confined immunogenic cell death. • Precise molecular activation improves the safety of antibody phototherapy.
Journal
IF:
11.5
Papers:
1.5W
Citations:
7.4W
Organization
No organization information available
Cited Papers